4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-040100
Chief Scientific Officer sold 11,685 shares at an average $37.32 ($436,065)
- Chief Scientific Officer acquired 11,685 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROBINS HARLAN S Chief Scientific Officer | 2021-06-09 | Option exercise | +3,895 | $6.32 | $24,616 | 73,255 | D |
| ROBINS HARLAN S Chief Scientific Officer | 2021-06-09 | Sale | −3,395 | $35.91 | $121,914 | 69,860 | D |
| ROBINS HARLAN S Chief Scientific Officer | 2021-06-09 | Sale | −500 | $36.50 | $18,250 | 69,360 | D |
| ROBINS HARLAN S Chief Scientific Officer | 2021-06-10 | Option exercise | +3,895 | $6.32 | $24,616 | 73,255 | D |
| ROBINS HARLAN S Chief Scientific Officer | 2021-06-10 | Sale | −1,100 | $36.77 | $40,447 | 72,155 | D |
| ROBINS HARLAN S Chief Scientific Officer | 2021-06-10 | Sale | −2,795 | $37.87 | $105,847 | 69,360 | D |
| ROBINS HARLAN S Chief Scientific Officer | 2021-06-11 | Option exercise | +3,895 | $6.32 | $24,616 | 73,255 | D |
| ROBINS HARLAN S Chief Scientific Officer | 2021-06-11 | Sale | −3,895 | $38.41 | $149,607 | 69,360 | D |
| Derivatives | |||||||
| ROBINS HARLAN S Chief Scientific Officer | 2021-06-09 | Option exercise · Stock Option (Right to Buy) | −3,895 | 124,640 | D | ||
| ROBINS HARLAN S Chief Scientific Officer | 2021-06-10 | Option exercise · Stock Option (Right to Buy) | −3,895 | 120,745 | D | ||
| ROBINS HARLAN S Chief Scientific Officer | 2021-06-11 | Option exercise · Stock Option (Right to Buy) | −3,895 | 116,850 | D | ||
| Open-market sales · 11,685 sh · avg $37.32 · $436,065 | |||||||
Loading xslF345X03/doc4.xml…